510(k) Report

510(k) · Cleared

Cleared

Pulsioflex Monitoring System with Picco Module

K122121510(k) SpecialCleared Aug 2, 201216-day reviewClass II21 CFR 870.1435

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Pulsion Medical Systems SE · DXG Computer, Diagnostic, Pre-Programmed, Single-Function

Cleared on Aug 2, 2012 after a 16-day review. FDA’s file for it is a 510(k) statement, which names no predicate. 4 later devices descend from it.

Decided
Aug 2, 2012
Review
16 days
Class
Class II
Product code
DXG
Recalls
None
Predicates
0

4 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2018: 1 descendant cleared2020: 1 descendant cleared2019: 1 descendant cleared2023: 1 descendant cleared2010201520202025
  1. This deviceK122121 Pulsioflex Monitoring System with Picco ModulePulsion Medical Systems SE · 2012
  2. Descendant · cites it directly · 3 of its ownK172259 PulsioFlex Monitoring SystemPulsion Medical Systems SE · 2018 · Recalled
  3. Descendant · 2 generations on · 1 of its ownK183521 CNAP MonitorCnsystems Medizintechnik GmbH · 2019
  4. Descendant · 3 generations on · 0 of its ownK223332 Task Force CORECnsystems Medizintechnik GmbH · 2023
  5. Descendant · 2 generations on · 0 of its ownK192169 PulsioFlex Monitoring System with ProAQT SensorPulsion Medical Systems SE · 2020

Most influential descendants

Showing 4 of 4 · See all
  • K172259PulsioFlex Monitoring SystemPulsion Medical Systems SE · 2018 · cites it directly3descendants
  • K183521CNAP MonitorCnsystems Medizintechnik GmbH · 2019 · 2 generations on1descendant
  • K223332Task Force CORECnsystems Medizintechnik GmbH · 2023 · 3 generations on0descendants
  • K192169PulsioFlex Monitoring System with ProAQT SensorPulsion Medical Systems SE · 2020 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K122121Pulsioflex Monitoring System with Picco ModulePulsion Medical Systems SE2012—
+1K172259PulsioFlex Monitoring SystemPulsion Medical Systems SE20181
+2K183521CNAP MonitorCnsystems Medizintechnik GmbH2019—
+3K223332Task Force CORECnsystems Medizintechnik GmbH2023—
+2K192169PulsioFlex Monitoring System with ProAQT SensorPulsion Medical Systems SE2020—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201810
201910
202010
202310
FIG. 1 — Lineage of K122121, 2012–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DXG? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DXG device

  1. #1 K253092 Argos Infinity (Rev. 1.0)score 11.1 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it? (4)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K172259PulsioFlex Monitoring SystemPulsion Medical Systems SE20183

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K172259 (Pulsion Medical Systems SE, 2018) has gone furthest, with 3 descendants of its own.

How does its category compare?

All DXG devices

DXG Computer, Diagnostic, Pre-Programmed, Single-Function: FDA decisions, review times, recalls and adverse event reports over 20 years. 2012, this device’s year, is highlighted.

FDA decisions per year · DXG

1in 2025

2007: 12008: 52010: 42011: 32012: 22013: 32014: 62015: 12016: 12017: 12018: 22019: 22020: 12021: 12023: 12025: 12026 (partial year): 1
2007high 6 (2014) · low 0 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DXG

290in 2014

2008: 118 days median2010: 282 days median2011: 104 days median2013: 236 days median2014: 290 days median
2007high 290 (2014) · low 104 (2011)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DXG

2in 2020

2007: 12008: 12009: 62010: 12020: 2
2007high 6 (2009) · low 0 (2011)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DXG

8in 2025

2007: 432008: 372009: 82010: 172011: 72012: 292013: 232014: 442015: 342016: 672017: 622018: 832019: 812020: 492021: 292022: 442023: 122024: 212025: 8
2007high 83 (2018) · low 7 (2011)2025

MAUDE reports naming product code DXG, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—143
20085118137
20090—68
20104282117
2011310407
20122—029
20133236023
20146290044
20151—034
20161—067
20171—062
20182—083
20192—081
20201—249
20211—029
20220—044
20231—012
20240—021
20251—08
20261—0—

What is it indicated for?

The PULSION PulsioFlex Monitoring System with optional PiCCO Module is intended for determination and monitoring of cardiopulmonary and circulatory variables. With the optional CeVox oximetry module connected to a compatible oximetry probe, the PulsioFlex Monitoring System with PiCCO Module measures oxygen saturation to assess oxygen delivery and consumption in adults and pediatrics. Cardiac output is determined both continuously through pulse contour…

Read the full statement (131 words)

The PULSION PulsioFlex Monitoring System with optional PiCCO Module is intended for determination and monitoring of cardiopulmonary and circulatory variables. With the optional CeVox oximetry module connected to a compatible oximetry probe, the PulsioFlex Monitoring System with PiCCO Module measures oxygen saturation to assess oxygen delivery and consumption in adults and pediatrics. Cardiac output is determined both continuously through pulse contour analysis and intermittently through thermodilution technique. In addition, the PulsioFlex Monitoring System measures heart rate, systolic, and diastolic and derives mean arterial and central venous pressure. Analysis of thermodilution curve in terms of mean transit time and downslope time is used for the determination of intravascular and extravascular fluid volumes. If a patient's weight and height are entered, the PulsioFlex monitor presents the derived parameters indexed to body surface area.

Indications for use as stated in the FDA 510(k) statement.

Cite this page

510(k) Report. “K122121: Pulsioflex Monitoring System with Picco Module.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K122121

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026